MX2020000288A - Cromatografia. - Google Patents

Cromatografia.

Info

Publication number
MX2020000288A
MX2020000288A MX2020000288A MX2020000288A MX2020000288A MX 2020000288 A MX2020000288 A MX 2020000288A MX 2020000288 A MX2020000288 A MX 2020000288A MX 2020000288 A MX2020000288 A MX 2020000288A MX 2020000288 A MX2020000288 A MX 2020000288A
Authority
MX
Mexico
Prior art keywords
purification
protein
chromatography step
chromatography
antibody
Prior art date
Application number
MX2020000288A
Other languages
English (en)
Inventor
Michael Harry Rose
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of MX2020000288A publication Critical patent/MX2020000288A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1814—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns recycling of the fraction to be distributed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/24—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
    • B01D15/245—Adding materials to the effluents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/24—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
    • B01D15/247—Fraction collectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sustainable Development (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

La presente invención está en el campo de la purificación y la purificación de proteínas en particular. La invención proporciona técnicas mejoradas para la purificación a escala industrial de proteínas y otras biomoléculas. Más específicamente, se refiere a un proceso para la purificación de un compuesto de interés, tal como una proteína, preferiblemente un anticuerpo o un fragmento de anticuerpo con el uso de un paso de cromatografía, preferiblemente un paso de cromatografía semicontinua.
MX2020000288A 2017-07-17 2018-07-16 Cromatografia. MX2020000288A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1711481.0A GB201711481D0 (en) 2017-07-17 2017-07-17 Protein purification
PCT/EP2018/069298 WO2019016154A1 (en) 2017-07-17 2018-07-16 Chromatography

Publications (1)

Publication Number Publication Date
MX2020000288A true MX2020000288A (es) 2020-07-22

Family

ID=59713705

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020000288A MX2020000288A (es) 2017-07-17 2018-07-16 Cromatografia.

Country Status (16)

Country Link
US (1) US11498941B2 (es)
EP (1) EP3655420A1 (es)
JP (1) JP7145196B2 (es)
KR (1) KR102542274B1 (es)
CN (1) CN110945008A (es)
AU (1) AU2018304867A1 (es)
BR (1) BR112019027760A2 (es)
CA (1) CA3067496A1 (es)
CL (1) CL2020000087A1 (es)
CO (1) CO2020000090A2 (es)
EA (1) EA202090262A1 (es)
GB (1) GB201711481D0 (es)
IL (1) IL271790B1 (es)
MX (1) MX2020000288A (es)
SG (1) SG11201911880UA (es)
WO (1) WO2019016154A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201916961D0 (en) * 2019-11-21 2020-01-08 Puridify Ltd Method in bioprocess purification system
JP2023513903A (ja) 2020-02-13 2023-04-04 エフ． ホフマン－ラ ロシュ アーゲー 核磁気共鳴緩和測定によってａａｖ粒子のローディング状態を決定するための方法
EP4083053A1 (en) * 2021-04-30 2022-11-02 Fresenius Kabi iPSUM S.r.l. Method for icatibant preparation
WO2023017126A1 (en) * 2021-08-13 2023-02-16 Bluetech Aps Industrial method for isolating an analyte from a liquid mixture
TW202337900A (zh) * 2022-01-12 2023-10-01 美商再生元醫藥公司 改良使用親和層析的異二聚蛋白質自雜質之解析的方法
WO2023178329A1 (en) * 2022-03-18 2023-09-21 Bristol-Myers Squibb Company Methods of isolating polypeptides
WO2024056626A1 (en) * 2022-09-13 2024-03-21 Sanofi Aventis Deutschland Gmbh Continuous gradient elution chromatographic fractionation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5940161A (ja) 1982-08-30 1984-03-05 Asahi Chem Ind Co Ltd カラムクロマトグラフイ−による分取方法
JPS61270658A (ja) * 1985-05-25 1986-11-29 Hitachi Plant Eng & Constr Co Ltd 分離精製装置
DE102005026486A1 (de) * 2005-06-09 2006-12-14 Bayer Technology Services Gmbh Ein chromatographisches quasi-kontinuierliches Verfahren und entsprechende Vorrichtung zur Trennung von binären und Mehrstoffgemischen
US8569464B2 (en) * 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
CA2856216C (en) 2011-11-11 2021-01-12 Ucb Pharma S.A. Albumin binding antibodies and binding fragments thereof
KR20200008022A (ko) 2011-12-22 2020-01-22 제넨테크, 인크. 이온 교환 막 크로마토그래피
EP2836515A1 (en) * 2013-03-14 2015-02-18 AbbVie Inc. Low acidic species compositions and methods for producing and using the same
DK3301115T3 (da) * 2013-05-06 2022-01-31 Sanofi Sa Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer
GB2528301A (en) 2014-07-17 2016-01-20 Univ Newcastle Biomolecule separation using apatite
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification

Also Published As

Publication number Publication date
KR20200027552A (ko) 2020-03-12
CN110945008A (zh) 2020-03-31
JP2020527553A (ja) 2020-09-10
SG11201911880UA (en) 2020-01-30
EA202090262A1 (ru) 2020-05-12
US11498941B2 (en) 2022-11-15
CL2020000087A1 (es) 2020-07-24
AU2018304867A1 (en) 2020-01-02
JP7145196B2 (ja) 2022-09-30
EP3655420A1 (en) 2020-05-27
CO2020000090A2 (es) 2020-04-24
IL271790A (en) 2020-02-27
BR112019027760A2 (pt) 2020-07-07
KR102542274B1 (ko) 2023-06-12
WO2019016154A1 (en) 2019-01-24
US20200331960A1 (en) 2020-10-22
IL271790B1 (en) 2024-05-01
GB201711481D0 (en) 2017-08-30
CA3067496A1 (en) 2019-01-24

Similar Documents

Publication Publication Date Title
MX2020000288A (es) Cromatografia.
EA201790247A1 (ru) Платформа для очистки биспецифичных антител
EA201890039A1 (ru) Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения
EA201990321A1 (ru) Биспецифические антителоподобные связывающие белки, которые специфически связываются с cd3 и cd123
EA201891709A1 (ru) Антигенсвязывающие белки, связывающие pd-l1
PH12016501937A1 (en) Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage
EA201891878A1 (ru) Очистка белков
WO2018194496A3 (ru) Моноклональное антитело к pd-l1
EP3543335A3 (en) Soluble intein fusion proteins and methods for purifying biomolecules
EA201691589A1 (ru) Стабилизированные основанные на фибронектине каркасные молекулы
EA201491564A1 (ru) Осаждение фракции i-iv-1 иммуноглобулинов из плазмы
BR112021017801A2 (pt) Anticorpos biespecíficos anti-vbeta17/anti-cd123
MX2022012042A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
MX2021001418A (es) Produccion de proteinas heteromultimericas usando celulas de mamifero.
EA202090084A1 (ru) Новый терапевтический ферментный слитый белок и его применение
PH12016500403A1 (en) An anti serum albumin fab-effector moiety fusion construct, and the preparing method thereof
MX2021000155A (es) Moleculas de proteina multifuncionales que comprenden decorina y su uso.
EA201990052A1 (ru) ПОЛУЧЕНИЕ ПРОИЗВОДНЫХ ФАКТОРА Ха
BR112017003263A2 (pt) anticorpos anti-vasa, e métodos de produção e utilização dos mesmos
EA201890171A1 (ru) Слитые белки btla агонисты и их применение
WO2014151834A3 (en) Methods and compositions relating to anti-ccr7 antigen binding proteins
PH12019502449A1 (en) Anti-jagged1 antigen binding proteins
EA201690942A1 (ru) Антитела к ccl17
NZ724772A (en) Antibodies against hpa-1a
MX2021015976A (es) Fusiones de inmunoglobulina y transtiretina multiespecificas.